Clinical trials
GAD clinical trials
Below are recruiting gad clinical trials, each written for real people, not researchers. We’re tracking 32 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06243640RecruitingPhase 3
New capsule for generalized anxiety disorder trial
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
Beijing, Beijing MunicipalityAges 18–65 - NCT06243614RecruitingPhase 3
Testing buagafuran capsules for generalized anxiety disorder
This trial tests a new medication called buagafuran for people with generalized anxiety disorder (GAD). It aims to see if the drug can safely reduce anxiety symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT06084520Recruiting
Pain questionnaire study for opioid and non-opioid patients
This study tests two questionnaires for people with long-term pain. Researchers want to see if the tools work well for both those taking opioids and those who are not. Your answers can help improve pain care.
Uppsala, UpplandAges 18–75 - NCT07819773Recruiting
Device for treating generalized anxiety
This study tests a device that uses magnetic pulses to stimulate the brain, which may help reduce symptoms of generalized anxiety disorder (GAD). The treatment is non-invasive and does not require surgery.
Denver, ColoradoAges 22 years+ - NCT07807865RecruitingPhase 3
Testing a new anxiety medication for safety
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07798063Recruiting
Solution-focused therapy for generalized anxiety
This study tests a type of talk therapy called solution-focused therapy to help young adults with mild to moderate generalized anxiety. It may help you learn practical ways to manage anxiety and improve your well-being.
IslamabadAges 18–29 - NCT07604753Recruiting
Comparing two mental health screening questionnaires
This study compares two different questionnaires that doctors use to diagnose mental health conditions. Researchers want to check if a newer, shorter questionnaire works just as well as the longer standard one.
Hong KongAges 18 years+ - NCT07429578Recruiting
Brain stimulation for anxiety and insomnia
This study tests whether a gentle, non-invasive brain stimulation technique (tACS) can help people who have both generalized anxiety and long-term sleep problems. It aims to see if this treatment can reduce anxiety and improve sleep.
São Paulo, São PauloAges 18–65 - NCT07430800Recruiting
AI-Powered CBT for Anxiety in University Students
This study tests whether personalized computer models can improve cognitive behavioral therapy (a talk therapy that helps change thinking patterns) for anxiety. It's for university students who have mild to moderate anxiety and are comfortable with being recorded during sessions.
Los Angeles, CaliforniaAges 18 years+ - NCT06823492Recruiting
Early life and brain study
This study looks at how your early life experiences may affect your brain and behavior. You would visit the University of Manchester for assessments and help researchers understand these connections.
ManchesterAges 18–25 - NCT07399327Recruiting
SEEG thermocoagulation for hard-to-treat epilepsy
This study is looking at how well a procedure called SEEG thermocoagulation (a way to stop seizures by heating a small area of brain tissue) works for people with epilepsy that doesn't improve with medication. By joining, you will help doctors understand why this treatment works for some people and not others.
MarseilleAges 12 years+ - NCT06831708Recruiting
Comparing two types of talk therapy for generalized anxiety
This trial compares two short-term therapies—psychoanalytic and cognitive behavioral—for people with generalized anxiety disorder (GAD). It aims to see which approach works better over 12 weekly sessions.
IstanbulAges 18–65 - NCT06811311Recruiting
Hypnotherapy and Brain Activity in Generalized Anxiety Disorder
This study uses EEG (a brain wave test) to see how Ericksonian hypnotherapy, a gentle type of hypnosis, affects brain activity and anxiety symptoms in people with Generalized Anxiety Disorder (GAD) who are not currently in treatment or taking medication for anxiety.
IstanbulAges 18–65 - NCT07299916Enrolling by invitation
Brain stimulation and virtual reality for anxiety disorders
This trial tests if a combination of non-invasive brain stimulation (tDCS) and virtual reality meditation can reduce anxiety in people with Generalized Anxiety Disorder or related conditions. It aims to find a new, non-medication way to help manage symptoms.
Hong KongAges 16–70 - NCT07228143Recruiting
Stepped care for anxiety in children
This study tests a stepped care approach to treat anxiety disorders in children ages 7 to 17. It starts with a parent-led program and adds more support if needed, aiming to reduce anxiety symptoms.
Houston, TexasAges 7–17 - NCT07212075Recruiting
Digital twin study for mental health in diabetes
This study uses digital twins—a virtual model of your health—to track how your mental health changes with diabetes. It aims to find patterns that could help personalize mental health care.
Bad Mergentheim, Baden-WurttembergAges 18–80 - NCT07201844Recruiting
Does patient choice improve online anxiety treatment?
This trial tests whether letting patients choose their own treatment approach within an online therapy program helps them more for generalized anxiety disorder. You'd receive 10 weeks of internet-delivered cognitive behavior therapy (iCBT) from home.
Stockholm, SverigeAges 18 years+ - NCT07123467RecruitingPhase 3
Study on CBD and learning for generalized anxiety
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
Detroit, MichiganAges 18–45 - NCT03813290Recruiting
Brain-based therapy for teens with generalized anxiety
This trial tests a neuro-based treatment to help adolescents with generalized anxiety disorder, including those newly diagnosed. You may be able to join if you meet age, diagnosis, and safety requirements, and if you have not already tried certain mindfulness programs.
Singapore, SingaporeAges 13–18 - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT06969170RecruitingPhase 2
Psilocybin oral solution for generalized anxiety disorder trial
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
Kingston, OntarioAges 18–60 - NCT06937892Recruiting
Metacognitive therapy vs. Cognitive therapy for anxiety
This study compares two different types of therapy for anxiety disorders: metacognitive therapy (which focuses on how you think about your thoughts) versus cognitive-behavioral therapy (which works on changing thoughts and behaviors). It may help you find which approach works best for you.
StockholmAges 18 years+ - NCT06931236Enrolling by invitation
Brain stimulation for anxiety and insomnia
This study tests whether a noninvasive brain stimulation technique called rTMS can help people with both anxiety and insomnia. Treatments target a specific brain region to reduce anxiety and improve sleep.
Hefei, AnhuiAges 15–65 - NCT06856161Recruiting
Blood test to help diagnose mental health conditions
This study is testing a new blood test that might help doctors better understand and diagnose conditions like depression, psychosis, or schizophrenia. If you are 19 or older and have one of these conditions, you may be able to join.
New Westminster, British ColumbiaAges 19 years+
Hear when a new GAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gad?
- Yes. Clin2 currently lists 32 recruiting gad studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gad trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gad trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.